Defense Health Agency Contracting Activity - DHACA
· Federal agency
DoD Military Burn, Clinical Translational Research Award
The MBRP CTRA is intended to support the rapid implementation of clinical research (including clinical trials) with the potential to significantly impact burn care by applying promising and well-founded research findings...
61
match
Deadline1019 days agoLocationAlabamaTypegrantLevelFederalClosedposted Apr 26, 2023
✦ AI Summary
Who can apply: Federal-level applicants (see eligibility for details).
Funding amount: total funding pool ~$4,000,000.
Next deadline: September 5, 2023.
Issued by: Defense Health Agency Contracting Activity - DHACA.
The “key facts” mode pulls structured fields directly from the official source posting (amount, deadline, eligibility tags). The AI mode adds a short plain-English narrative on top, generated from the same source. Always verify with the agency before applying.
AI-generated. Always verify with the official source.
Deadline
1019 days ago
Sep 5, 2023
Total pool
$4M
About this opportunity
The MBRP CTRA is intended to support the rapid implementation of clinical research (including clinical trials) with the potential to significantly impact burn care by applying promising and well-founded research findings to the care of the burn-injured patient, particularly at the point of injury, or during the early, acute phase of burn injury (Roles 1-3 of the military pathway of care).4Impact: The overall impact of the proposed research is a key component of this award mechanism. The potential impact of the research, both short term and long term, in addressing one or more of the FY23 MBRP Focus Areas should be clearly described. Investigators are encouraged to consider the following characteristics as examples of how a project may demonstrate highly impactful research:• Description of how the proposed research addresses a military need within Roles 1-3 of the military pathway of care4• Explanation of how the project significantly advances the burn research field and the care of burn-injured service members in an austere or resource limited environment• Description of how the proposed research will support the ability to provide care to burn injured patients at, or close to the point of injury, particularly by a combat medic (or equivalent), or a non-medical first responderRelevance to Military Health: The proposed research must be relevant to Service beneficiaries, and/or the American public. Investigators are encouraged to consider the following characteristics as examples of how a project may demonstrate relevance to military health:• Explanation of how the project addresses an aspect of burn injuries typically associated with combat• Description of how the results of the proposed research will address a military needCollaborations between researchers at military or Veteran institutions and non-military institutions are strongly encouraged. These relationships can leverage access to unique data and research resources that the partners bring to the research effort, ultimately advancing burn research, which is of significance to the Service Member, military families, and the American public.Inclusion of preliminary data relevant to the proposed clinical research is required.The following are important aspects of the FY23 MBRP CTRA:• The proposed clinical research study must be based on sound scientific rationale that is established through logical reasoning and critical review and analysis of the literature.• Enrollment for the proposed clinical research study is expected to begin no later than 9 months after the award date.• The application should demonstrate availability of, and access to, a suitable patient population that will support a meaningful outcome for the study.• The application should include a clearly articulated statistical analysis plan, appropriate statistical expertise on the research team, and a power analysis reflecting sample size projections that will answer the objectives of the study.• The application should include a Transition Plan (including potential funding and resources) showing how the product will progress to the next clinical phase and/or delivery to the market after the successful completion of the FY23 MBRP CTRA.• Funded studies that contain clinical trials are required to register the study in the National Institutes of Health (NIH) clinical trials registry, www.clinicaltrials.gov, prior to initiation of the study. Refer to the General Application Instructions, Appendix 1, Section C, for further details.• If proposing a clinical trial that involves the use of a drug that has not been approved by the Food and Drug Administration (FDA) for the proposed investigational use, an Investigational New Drug (IND) application to the FDA that meets all requirements under the Code of Federal Regulations, Title 21, Part 312 (21 CFR 312) may be required and must be submitted to the FDA within 2 months (60 calendar days) of the award date.
Read the agency's eligibility checklist before you start — it's almost always shorter than the full NOFO and will tell you in 90 seconds whether to keep going.
Need help getting in touch with the right agency contact?
Create a free account and our specialists will guide you through the application end-to-end.